Search Results - Editorial Plus,

Editorial: « Plus de futur »: quel rôle pour la prospective ?

Authors: JOFFRE, Patrick

Source: Revue Management et Avenir. jun2025, Issue 147, p9-13. 5p.

Editorial Comment on "Comparison of Infectious Complications After Transrectal Prostate Biopsy Under Two Antibiotic Prophylaxis Regimens: Ceftriaxone Plus Cefixime Versus Ciprofloxacin Plus Gentamicin".

Authors: Razdan S; Miami Robotic Surgery, Miami, Florida, USA.

Source: International journal of urology : official journal of the Japanese Urological Association [Int J Urol] 2026 May; Vol. 33 (5), pp. e70466.

Publication Type: Journal Article

Journal Info: Publisher: Blackwell Science Asia Country of Publication: Australia NLM ID: 9440237 Publication Model: Print Cited Medium: Internet ISSN: 1442-2042 (Electronic) Linking ISSN: 09198172 NLM ISO Abbreviation: Int J Urol Subsets: MEDLINE; In Process

Editorial Comment on Comparison of Infectious Complications After Transrectal Prostate Biopsy Under Two Antibiotic Prophylaxis Regimens: Ceftriaxone Plus Cefixime Versus Ciprofloxacin Plus Gentamicin.

Authors: Sekito T Hirakawa H Sadahira T

Source: International journal of urology : official journal of the Japanese Urological Association [Int J Urol] 2026 May; Vol. 33 (5), pp. e70464.

Publication Type: Journal Article

Journal Info: Publisher: Blackwell Science Asia Country of Publication: Australia NLM ID: 9440237 Publication Model: Print Cited Medium: Internet ISSN: 1442-2042 (Electronic) Linking ISSN: 09198172 NLM ISO Abbreviation: Int J Urol Subsets: MEDLINE; In Process

Editorial Comment to Niraparib With Abiraterone Acetate Plus Prednisone as First-Line Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer With Homologous Recombination Repair Gene Alterations: Final Analysis of the Asian Subgroup From the MAGNITUDE Study.

Authors: Miyazawa Y; Department of Urology, Gunma University Graduate School of Medicine & Gunma University Hospital, Maebashi, Japan.

Source: International journal of urology : official journal of the Japanese Urological Association [Int J Urol] 2026 May; Vol. 33 (5), pp. e70488.

Publication Type: Journal Article

Journal Info: Publisher: Blackwell Science Asia Country of Publication: Australia NLM ID: 9440237 Publication Model: Print Cited Medium: Internet ISSN: 1442-2042 (Electronic) Linking ISSN: 09198172 NLM ISO Abbreviation: Int J Urol Subsets: MEDLINE; In Process

Editorial: Regorafenib Plus Nivolumab in Advanced Hepatocellular Carcinoma-A Step Toward Mechanism-Guided Second-Line Therapy.

Authors: Kuo YH Hung CH

Source: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2026 Mar 17. Date of Electronic Publication: 2026 Mar 17.

Publication Type: Editorial

Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE

Ibrutinib plus venetoclax for patients with relapsed or refractory mantle cell lymphoma: an editorial on the phase 3 SYMPATICO trial.

Authors: Reef DK Grover N

Source: AME clinical trials review [AME Clin Trials Rev] 2026 Apr 25; Vol. 4. Date of Electronic Publication: 2025 Dec 17.

Publication Type: Journal Article

Journal Info: Publisher: AME Publishing Company Country of Publication: China NLM ID: 9918994995006676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 3005-6152 (Electronic) Linking ISSN: 30056152 NLM ISO Abbreviation: AME Clin Trials Rev Subsets: PubMed not MEDLINE

Editorial Comment on Bayesian Reanalysis of Enzalutamide Plus Androgen Deprivation Therapy in Japanese Patients With Metastatic Hormone-Sensitive Prostate Cancer: A Methodological Complement to Frequentist Analysis From the ARCHES Trial.

Authors: Urabe F; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.

Source: International journal of urology : official journal of the Japanese Urological Association [Int J Urol] 2026 Jan; Vol. 33 (1), pp. e70269. Date of Electronic Publication: 2025 Oct 26.

Publication Type: Journal Article

Journal Info: Publisher: Blackwell Science Asia Country of Publication: Australia NLM ID: 9440237 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1442-2042 (Electronic) Linking ISSN: 09198172 NLM ISO Abbreviation: Int J Urol Subsets: MEDLINE; In Process

Correspondence to editorial 1 on "Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: insights from the IMbrave150 Trial".

Authors: Lee SH Yim SY Kim JH et al.

Source: Clinical and molecular hepatology [Clin Mol Hepatol] 2025 Jan; Vol. 31 (1), pp. e81-e83. Date of Electronic Publication: 2024 Oct 07.

Publication Type: Journal Article

Journal Info: Publisher: Korean Association for the Study of the Liver Country of Publication: Korea (South) NLM ID: 101586730 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2287-285X (Electronic) Linking ISSN: 22872728 NLM ISO Abbreviation: Clin Mol Hepatol Subsets: MEDLINE; In Process

Transcriptomic signature in advanced hepatocellular carcinoma tissue to predict combination immunotherapy response: Editorial on "Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial".

Authors: Kanzaki H Hoshida Y

Source: Clinical and molecular hepatology [Clin Mol Hepatol] 2025 Jan; Vol. 31 (1), pp. 308-310. Date of Electronic Publication: 2024 Aug 30.

Publication Type: Editorial

Journal Info: Publisher: Korean Association for the Study of the Liver Country of Publication: Korea (South) NLM ID: 101586730 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2287-285X (Electronic) Linking ISSN: 22872728 NLM ISO Abbreviation: Clin Mol Hepatol Subsets: MEDLINE; In Process

Personalized approaches to the treatment of hepatocellular carcinoma using immune checkpoint inhibitors: Editorial on "Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial".

Authors: Nishida N; Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Osaka, Japan.

Source: Clinical and molecular hepatology [Clin Mol Hepatol] 2025 Jan; Vol. 31 (1), pp. 311-315. Date of Electronic Publication: 2024 Sep 03.

Publication Type: Editorial

Journal Info: Publisher: Korean Association for the Study of the Liver Country of Publication: Korea (South) NLM ID: 101586730 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2287-285X (Electronic) Linking ISSN: 22872728 NLM ISO Abbreviation: Clin Mol Hepatol Subsets: MEDLINE; In Process

Correspondence to editorial 2 on "Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: insights from the IMbrave150 trial".

Authors: Yim SY Lee SH Kim JH et al.

Source: Clinical and molecular hepatology [Clin Mol Hepatol] 2025 Jan; Vol. 31 (1), pp. e84-e86. Date of Electronic Publication: 2024 Oct 07.

Publication Type: Journal Article

Journal Info: Publisher: Korean Association for the Study of the Liver Country of Publication: Korea (South) NLM ID: 101586730 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2287-285X (Electronic) Linking ISSN: 22872728 NLM ISO Abbreviation: Clin Mol Hepatol Subsets: MEDLINE; In Process

Editorial Comment on "Efficacy of pembrolizumab plus lenvatinib as first-line treatment for metastatic renal cell carcinoma with multiple brain metastases".

Authors: Kato M; Department of Urology Aichi Cancer Center Hospital Nagoya Aichi Japan.

Source: IJU case reports [IJU Case Rep] 2024 Nov 12; Vol. 8 (1), pp. 9-10. Date of Electronic Publication: 2024 Nov 12 (Print Publication: 2025).

Publication Type: Editorial

Journal Info: Publisher: John Wiley & Sons Australia, Ltd Country of Publication: Australia NLM ID: 101764958 Publication Model: eCollection Cited Medium: Internet ISSN: 2577-171X (Electronic) Linking ISSN: 2577171X NLM ISO Abbreviation: IJU Case Rep Subsets: PubMed not MEDLINE

Editorial Comment on "Efficacy and safety of dose-dense gemcitabine plus cisplatin as neoadjuvant chemotherapy for muscle-invasive bladder cancer".

Authors: Urabe F Suzuki H Iwatani K et al.

Source: International journal of urology : official journal of the Japanese Urological Association [Int J Urol] 2024 Oct; Vol. 31 (10), pp. 1107. Date of Electronic Publication: 2024 Jul 16.

Publication Type: Editorial

Journal Info: Publisher: Blackwell Science Asia Country of Publication: Australia NLM ID: 9440237 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1442-2042 (Electronic) Linking ISSN: 09198172 NLM ISO Abbreviation: Int J Urol Subsets: MEDLINE

Editorial Comment to "Efficacy and safety of dose-dense gemcitabine plus cisplatin as neoadjuvant chemotherapy for muscle-invasive bladder cancer".

Authors: Kikuchi E Hayakawa N

Source: International journal of urology : official journal of the Japanese Urological Association [Int J Urol] 2024 Oct; Vol. 31 (10), pp. 1106. Date of Electronic Publication: 2024 Jul 16.

Publication Type: Editorial

Journal Info: Publisher: Blackwell Science Asia Country of Publication: Australia NLM ID: 9440237 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1442-2042 (Electronic) Linking ISSN: 09198172 NLM ISO Abbreviation: Int J Urol Subsets: MEDLINE

Editorial Commentary: Knee Osteotomy Plus Cartilage Restoration Is Not Always Superior to Osteotomy Alone.

Authors: Sherman SL Mastrocola M

Source: Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association [Arthroscopy] 2025 Aug; Vol. 41 (8), pp. 2985-2987. Date of Electronic Publication: 2025 Apr 12.

Publication Type: Editorial

Journal Info: Publisher: W.B. Saunders Co Country of Publication: United States NLM ID: 8506498 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1526-3231 (Electronic) Linking ISSN: 07498063 NLM ISO Abbreviation: Arthroscopy Subsets: MEDLINE

Editorial Comment from Dr Miyake to Real-world outcomes of avelumab plus axitinib as first-line therapy in patients with advanced renal cell carcinoma in Japan: A multicenter, retrospective, observational study (J-DART).

Authors: Miyake M; Department of Urology, Nara Medical University, Nara, Japan.

Source: International journal of urology : official journal of the Japanese Urological Association [Int J Urol] 2024 Mar; Vol. 31 (3), pp. 273. Date of Electronic Publication: 2024 Jan 03.

Publication Type: Editorial; Comment

Journal Info: Publisher: Blackwell Science Asia Country of Publication: Australia NLM ID: 9440237 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1442-2042 (Electronic) Linking ISSN: 09198172 NLM ISO Abbreviation: Int J Urol Subsets: MEDLINE

L'écriture journalistique, quels vocables ? Cas des éditoriaux marocains d'expression française L'Opinion et Aujourd'hui le Maroc en période de confinement de la crise sanitaire COVID-19.

Alternate Title: Journalistic Writing, Which Vocabulary? The Case of FrenchLanguage Moroccan Editorials L'Opinion and Aujourd'hui le Maroc During the COVID-19 Lockdown.

Authors: OUALLOU, ZAKARIA¹

Source: Nouvelles Perspectives en Sciences Sociales. 2026, Vol. 21 Issue 2, p511-532. 22p.

Reply to Editorial Comment on "A Comparison Between Intravesical Gemcitabine Plus Docetaxel and Intravesical Bacillus Calmette-Guérin in the Treatment of Nonmuscle Invasive Naive Urinary Bladder Cancer: A Systematic Review and Meta-analysis of Oncological Outcomes".

Authors: Tripathy R Kumar L

Source: Urology [Urology] 2025 May; Vol. 199, pp. 181. Date of Electronic Publication: 2025 Feb 19.

Publication Type: Journal Article; Comment

Journal Info: Publisher: Elsevier Science Country of Publication: United States NLM ID: 0366151 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-9995 (Electronic) Linking ISSN: 00904295 NLM ISO Abbreviation: Urology Subsets: MEDLINE; In Process

Editorial Comment on "A Comparison Between Intravesical Gemcitabine Plus Docetaxel and Intravesical Bacillus Calmette-Guérin in the Treatment of Nonmuscle Invasive Naive Urinary Bladder Cancer: A Systematic Review and Meta-analysis of Oncological Outcomes".

Authors: Michael PD Campbell RA

Source: Urology [Urology] 2025 May; Vol. 199, pp. 179-180. Date of Electronic Publication: 2025 Feb 10.

Publication Type: Journal Article; Comment

Journal Info: Publisher: Elsevier Science Country of Publication: United States NLM ID: 0366151 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-9995 (Electronic) Linking ISSN: 00904295 NLM ISO Abbreviation: Urology Subsets: MEDLINE; In Process

Editorial Comment on Clinical outcomes of nivolumab plus ipilimumab in patients with metastatic non-clear cell renal cell carcinoma: Real-world data from a Japanese multicenter retrospective study.

Authors: Yuasa T; Department of Urology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.

Source: International journal of urology : official journal of the Japanese Urological Association [Int J Urol] 2023 Sep; Vol. 30 (9), pp. 721-722. Date of Electronic Publication: 2023 Jan 18.

Publication Type: Editorial; Comment

Journal Info: Publisher: Blackwell Science Asia Country of Publication: Australia NLM ID: 9440237 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1442-2042 (Electronic) Linking ISSN: 09198172 NLM ISO Abbreviation: Int J Urol Subsets: MEDLINE